Repertor.IO: Patient Preference evidence & Healthcare collaboration

Patient Preference Information is becoming increasingly relevant and informative for clinical trial design, regulatory dossiers and, more broadly, for building truly patient-centred healthcare.

We are looking to connect with pharma and biotech companies, HTA bodies and CROs to understand how patient preference evidence is currently used in practice, explore where it could add value, and identify opportunities for collaboration.